News Headlines Article

Pfizer Hopes to Pair Cancer Drug, Gene Test
New York Times

Pfizer plans to submit its proposed new lung cancer drug to the Food and Drug Administration in the first half of next year at the same time that it submits a gene diagnostic test being developed with Abbott to identify patients most likely to benefit from the drug, company officials said Thursday.

“It’s moving us one step closer to our goal of personalized medicines, something we’ve been talking about for more than a decade,” Dr. Mace L. Rothenberg, Pfizer’s senior vice president of clinical development in oncology, told reporters at a company briefing.